Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Catalent to Sell Somerset Oral Solids Facility to Ardena
Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset to Ardena
Catalent to sell New Jersey facility
Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on Monday. Catalent provides contract manufacturing services and performs fill-finish work,
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that it has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset,
Catalent to sell Somerset HQ (updated)
The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, which is in talks with Novo Holdings for a $16.5 billion acquisition.
Catalent To Sell Oral Solids Development Facility In Somerset, NJ To Ardena
Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer
Catalent to sell Somerset oral solids facility
Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to contract manufacturer Ardena. Financial details of the agreement, which is expected to close in early 2025,
4d
Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...
Zacks.com on MSN
2d
Catalent Stock Flat Following the Sell Agreement With Ardena
Catalent CTLT recently announced that it has entered into a definitive agreement to sell its oral solids development and ...
FiercePharma
4d
Catalent offloads New Jersey manufacturing plant, HQ to Belgian CDMO Ardena
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
biopharma-reporter
16d
Ardena debuts new nanomedicines facility at CPHI 2024
At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch ...
Reuters
9d
New Jersey News | Today's Latest Stories | Reuters
Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer
Ardena
, the companies said on Monday.
4d
Catalent同意将新泽西州工厂出售给Ardena
合同制造服务提供商Catalent已达成协议,将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商Ardena。该交易于今日宣布。 这座获得美国食品和药物管理局(FDA)批准的萨默塞特工厂拥有约200名科学家和技术人员。Ardena表示,收购这座工厂将增强其在口服药物商业化生产方面的能力。 Catalent以其灌装完成工作而闻名,包括为制药公司进行注射器和注射笔的无菌灌装 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback